logo

For the Inventor, By the Inventor

Jammu, India

Bal Krishan Chandan

USPTO Granted Patents = 9

Average Co-Inventor Count = 9.7

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:

goldMedal9 out of 2,096 
 
Council of Scientific and Industrial Research
 patents

Years Active: 2003-2010

Loading Chart...
9 patents (USPTO):Explore Patents
1. 7794753 - Synergistic hepatoprotective composition and a method thereof (2010-09-14),
2. 7259148 - Hepatoprotective activity of 2'-p-hydroxybenzoylmussaenosidic acid (2007-08-21),
3. 7118766 - Pharmaceutical composition and process for isolation of trans-tetracos-15-enoic acid and method of treatment for hepatotoxicity (2006-10-10),
4. 6989162 - Hepatoprotective agent of plant origin and a process thereof (2006-01-24),
5. 6949586 - Synergistic composition of trans-tetracos-15-enoic acid and Apocynin and method of treatment for hepatotoxicity (2005-09-27),
6. 6913772 - Composition useful as hepatoprotectants comprising extract of plant Cryptolepis buchanani and a method thereof (2005-07-05),
7. 6852759 - Process for the synthesis of trans-alkenoic acids, use thereof (2005-02-08),
8. 6686375 - Composition useful as hepatoprotectants comprising extract of plant Cryptolepis buchanani and a method thereof (2004-02-03),
9. 6664236 - Synergistic composition of bioactive fraction isolated from barleria prionitis linn and a method of treatment for hepatotoxicity, immuno-deficiency and fatigue and a process thereof (2003-12-16),

Title: Bal Krishan Chandan: Innovator in Hepatoprotection

Introduction

Bal Krishan Chandan is a notable inventor based in Jammu, India. He has made significant contributions to the field of hepatoprotection, holding a total of 9 patents. His work focuses on developing innovative formulations that aid in the treatment and prevention of liver diseases.

Latest Patents

Among his latest patents is a synergistic hepatoprotective composition and a method thereof. This invention relates to a formulation comprising trans-tetracos-15-enoic acid (t-TCA) and andrographolide (AP) in a specific ratio, which is useful in hepatoprotection. The process for preparing this formulation involves grounding the particles of t-TCA and AP into fine particles, mixing them in the specified ratio, and grinding the mixture to obtain the final formulation. Additionally, he has developed a method for hepatoprotection using this synergistic formulation, which includes administering the formulation to the subject. Another significant patent is related to the hepatoprotective activity of 2'-p-hydroxybenzoylmussaenosidic acid. This invention provides a method for treating and preventing hepatic disease conditions in mammals, including humans, by administering an effective dosage of a composition containing 2'-p-Hydroxy benzoyl mussaenosidic acid.

Career Highlights

Bal Krishan Chandan is associated with the Council of Scientific & Industrial Research, where he has been instrumental in advancing research in hepatoprotection. His innovative approaches have garnered attention in the scientific community, contributing to the development of effective treatments for liver-related ailments.

Collaborations

He has collaborated with notable colleagues such as Naresh Kumar Satti and Krishan Avtar Suri, enhancing the research output and innovation in his field.

Conclusion

Bal Krishan Chandan's contributions to hepatoprotection through his innovative patents highlight his dedication to improving health outcomes. His work continues to inspire advancements in the treatment of liver diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…